NUS researchers combine 3D bioprinting with AI to personalise oral soft tissue grafts

NUS researchers combine 3D bioprinting with AI to personalise oral soft tissue grafts

Artificial intelligence streamlines the optimisation of bioprinting parameters for oral soft tissue grafts, reducing time and resource demands while enabling efficient, personalised dental treatments SINGAPORE, April 4, 2025 /PRNewswire/ -- A team...

Henlius and Dr. Reddy's Ink Licensing Deal for HLX15 (investigational daratumumab biosimilar) Expansion in Europe and the U.S.

Henlius and Dr. Reddy's Ink Licensing Deal for HLX15 (investigational daratumumab biosimilar) Expansion in Europe and the U.S.

SHANGHAI, Feb. 6, 2025 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) today announced it has entered into a license agreement with Dr. Reddy's Laboratories SA, wholly-owned subsidiary of Dr. Reddy's Laboratories Ltd., (BSE: 500124 | NSE:...

menu
menu